Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (2TZ) Financial Statements

0 Followers

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Financial Overview

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's market cap is currently €3.38B. The company's EPS TTM is €2.844; its P/E ratio is 13.67; Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S is scheduled to report earnings on April 29, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 4.92B	¥ 7.31B	¥ 8.22B	¥ 8.25B	¥ 6.91B
Gross Profit	¥ 3.64B	¥ 3.52B	¥ 3.62B	¥ 3.29B	¥ 2.76B
Operating Income	¥ 2.49B	¥ 2.57B	¥ 1.10B	¥ 980.05M	¥ 866.68M
EBITDA	¥ 2.61B	¥ 2.74B	¥ 1.26B	¥ 1.11B	¥ 991.28M
Net Income	¥ 2.13B	¥ 2.23B	¥ 986.71M	¥ 861.79M	¥ 769.14M
Balance Sheet
Cash & Short-Term Investments	¥ 1.02B	¥ 3.94B	¥ 2.15B	¥ 2.88B	¥ 2.28B
Total Assets	¥ 11.69B	¥ 10.77B	¥ 10.23B	¥ 10.16B	¥ 9.07B
Total Debt	¥ 62.56M	¥ 27.26M	¥ 325.58M	¥ 257.91M	¥ 33.17M
Net Debt	¥ -953.87M	¥ -2.92B	¥ -1.80B	¥ -2.62B	¥ -2.25B
Total Liabilities	¥ 4.59B	¥ 2.92B	¥ 3.58B	¥ 3.61B	¥ 2.55B
Stockholders' Equity	¥ 7.10B	¥ 7.84B	¥ 6.60B	¥ 6.52B	¥ 6.36B
Cash Flow
Free Cash Flow	¥ 342.45M	¥ 806.86M	¥ 547.56M	¥ 569.34M	¥ 695.45M
Operating Cash Flow	¥ 461.07M	¥ 924.67M	¥ 688.49M	¥ 677.25M	¥ 852.40M
Investing Cash Flow	¥ -1.41B	¥ 342.31M	¥ -744.21M	¥ -12.28M	¥ -311.85M
Financing Cash Flow	¥ -980.88M	¥ -319.89M	¥ -836.65M	¥ -236.62M	¥ -244.70M

Currency in CNY

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Earnings and Revenue History

Income Statement >

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Debt to Assets

Balance Sheet >

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Cash Flow

Cash Flow >

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >